Cargando…
Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach
Pulmonary arterial hypertension (PAH) is a progressive disorder characterized by a sustained elevation of pulmonary artery (PA) pressure, right ventricular failure, and premature death. Enhanced proliferation and resistance to apoptosis (as seen in cancer cells) of PA smooth muscle cells (PASMCs) is...
Autores principales: | Habbout, Karima, Omura, Junichi, Awada, Charifa, Bourgeois, Alice, Grobs, Yann, Krishna, Vinod, Breuils-Bonnet, Sandra, Tremblay, Eve, Mkannez, Ghada, Martineau, Sandra, Nadeau, Valérie, Roux-Dalvai, Florence, Orcholski, Mark, Jeyaseelan, Jey, Gutstein, David, Potus, François, Provencher, Steeve, Bonnet, Sébastien, Paulin, Roxane, Boucherat, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999120/ https://www.ncbi.nlm.nih.gov/pubmed/33803922 http://dx.doi.org/10.3390/ijms22062957 |
Ejemplares similares
-
Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension
por: Grobs, Yann, et al.
Publicado: (2021) -
PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension
por: Shimauchi, Tsukasa, et al.
Publicado: (2022) -
HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension
por: Boucherat, Olivier, et al.
Publicado: (2017) -
Dual ET(A)/ET(B) blockade with macitentan improves both vascular remodeling and angiogenesis in pulmonary arterial hypertension
por: Nadeau, Valerie, et al.
Publicado: (2017) -
Pim-1: A new biomarker in pulmonary arterial hypertension
por: Renard, Sébastien, et al.
Publicado: (2013)